Aubagio, whose active ingredient is teriflunomide, is a medication commonly prescribed to treat multiple sclerosis (MS). One important consideration when taking Aubagio is its potential effect on blood pressure. Yes, **Aubagio can cause high blood pressure (hypertension)** or worsen existing hypertension in some patients.
Teriflunomide has been reported to lead to new onset hypertension or exacerbate pre-existing high blood pressure. Because of this risk, regular monitoring of blood pressure throughout the treatment period is essential. Patients starting Aubagio should have their blood pressure checked frequently so that any rise can be detected early and managed appropriately.
The mechanism behind this side effect isn’t fully detailed in simple terms but may relate to how teriflunomide affects the immune system and possibly vascular function indirectly. Since MS treatments modulate immune responses and inflammation, they can sometimes influence cardiovascular parameters like blood pressure.
Besides hypertension, Aubagio carries other significant risks such as liver toxicity and changes in blood cell counts; therefore, doctors usually perform routine liver function tests and complete blood counts during therapy. The first six months are particularly critical for monitoring these effects closely.
If a patient experiences symptoms suggestive of elevated blood pressure—such as headaches, dizziness, chest tightness—or if routine checks reveal increased readings, healthcare providers might adjust the dose or consider alternative therapies depending on severity.
In addition to medical monitoring:
– Patients are advised to maintain healthy lifestyle habits that support normal blood pressure levels: balanced diet low in salt, regular physical activity within tolerance limits for MS patients, avoiding smoking and excessive alcohol consumption.
– Reporting any unusual symptoms promptly helps prevent complications related to uncontrolled hypertension or other side effects from Aubagio.
While not everyone on Aubagio will develop high blood pressure, it remains an important possible adverse effect requiring vigilance by both patients and clinicians. Managing this risk effectively allows many people with MS to benefit from the drug’s disease-modifying properties while minimizing cardiovascular harm.
In summary: **Yes**, Aubagio can cause or worsen high blood pressure; careful ongoing monitoring combined with lifestyle measures forms the cornerstone of safe use regarding this issue during treatment with teriflunomide-based therapy.
